Related Experiment Video
Updated: Jul 11, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
YB-1 binds to the MMP-13 promoter sequence and represses MMP-13 transactivation via the AP-1 site
Shaija Samuel1, Katherine K Beifuss, Lori R Bernstein
1Department of Molecular and Cellular Medicine, Texas A&M University System Health Science Center, College Station, TX 77843-1114, USA.
Abstract:
Matrix metalloproteinases (MMPs) are key enzymes that implement degradation of the extracellular matrix during cellular invasion in development, tissue remodeling, and pathogenic disease states. MMP-13 has pivotal roles in the pathogenesis of invasive cancers and arthritis. Here we report the identification of Y-box binding protein-1 (YB-1) as a new repressor of MMP-13 transactivation. YB-1 binds in vitro in DNA affinity chromatography to the activator protein-1 (AP-1) DNA sequence within the MMP-13 promoter. Chromatin immunoprecipitation assays reveal that YB-1 binds in living cells to the MMP-13 gene promoter to a region of the MMP-13 promoter containing the AP-1 site. YB-1 represses tumor promoter-induced MMP-13 promoter transactivation at the AP-1 site. This is the first report demonstrating YB-1 binding in vitro and in living cells to a mammalian AP-1 target gene, and the first report of YB-1 regulation of the MMP-13 promoter.
Insights
Y-box binding protein-1 (YB-1) represses matrix metalloproteinase-13 (MMP-13) gene activation by binding to its promoter. This discovery reveals a new regulatory mechanism for MMP-13 in cancer and arthritis.
Area of Science:
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) degrade the extracellular matrix, crucial in development, tissue remodeling, and disease.
- MMP-13 is implicated in the pathogenesis of invasive cancers and arthritis.
Purpose of the Study:
- To identify novel regulators of MMP-13 transactivation.
- To investigate the role of Y-box binding protein-1 (YB-1) in MMP-13 gene expression.
Main Methods:
- DNA affinity chromatography to assess YB-1 binding to the MMP-13 promoter AP-1 site.
- Chromatin immunoprecipitation assays to confirm YB-1 binding in vivo.
- Reporter assays to evaluate YB-1's effect on MMP-13 promoter activity.
Main Results:
- YB-1 binds to the activator protein-1 (AP-1) DNA sequence in the MMP-13 promoter in vitro.
- YB-1 binds to the MMP-13 gene promoter in living cells.
- YB-1 represses tumor promoter-induced MMP-13 promoter transactivation.
Conclusions:
- YB-1 acts as a novel repressor of MMP-13 transactivation.
- This study demonstrates, for the first time, YB-1 binding to a mammalian AP-1 target gene promoter in vitro and in vivo.
- YB-1 regulation of the MMP-13 promoter offers new insights into cancer and arthritis pathogenesis.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
TGF - β Signaling Pathway
Abnormal Proliferation
Co-activators and Co-repressors
The JAK-STAT Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
A...

